Navigation Links
Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Joint Status Conference in Federal Litigations
Date:3/30/2013

New York, New York (PRWEB) March 30, 2013

As women in the U.S. continue to file transvaginal mesh lawsuits, Bernstein Liebhard LLP reports that the next status conference in the federal litigations underway in the U.S. District Court for the Southern District of West Virginia will be held on April 18th at 1:00 p.m. According to a calendar posted on the court’s website, this joint Status Conference will take place in four federal transvaginal mesh litigations: In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2325”); In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2326); In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2187”); and In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation (“ MDL No. 2327”). Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committees in all of these proceedings.

“We continue to hear from women who experienced the dangerous side effects of vaginal mesh. We are pleased to see these litigations moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm has filed transvaginal mesh lawsuits on behalf of hundreds of women who suffered pain, scarring, mesh erosion, infection and other side effects stemming from the surgical material. Claims pending in the four federal litigations of transvaginal mesh lawsuits were filed over products marketed by American Medical Systems, Inc., C.R. Bard, Inc., Ethicon, Inc. and Boston Scientific Corp.

Transvaginal Mesh Lawsuits
The number of lawsuits filed in the nationwide litigation surrounding transvaginal mesh has steadily increased since 2011, when the U.S. Food and Drug Administration (FDA) issued a public health alert stating there had been a five-fold increase in the amount of adverse event reports of transvaginal mesh complications filed with the agency. In the warning, the FDA also re-classified the frequency of vaginal mesh injuries stemming from pelvic organ prolapse repair as “not rare,” which was upgraded from its previous position that frequency of such complications was “rare.”*
Consolidated proceedings for transvaginal mesh lawsuits filed over products manufactured by Johnson & Johnson’s Ethicon unit and C.R. Bard are underway in New Jersey Superior Court, Atlantic County as well. (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10, and In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10).
In both of these litigations, Bernstein Liebhard LLP partner, Jeffrey S. Grand is serving as Co-Liaison Counsel. Earlier this month, a jury in New Jersey Superior Court awarded more than $11 million to the Plaintiff in the nation’s first trial involving an Ethicon mesh product. As part of this reward, Johnson & Johnson was ordered to pay the Plaintiff $7.76 million in punitive damages. Mr. Grand was a member of the trial team. (Gross v. Gynecare Inc., Atl-L-6966-10, Superior Court of Atlantic County, New Jersey (Atlantic City))

Women who allegedly suffered transvaginal mesh complications after being implanted with the surgical material may be entitled to compensation for medical expenses, pain and suffering, and other damages incurred by their injuries. A wealth of transvaginal mesh lawsuit information can be found at Bernstein Liebhard's website. Please call 1-877-779-1414 to learn more.

*fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/UroGynSurgicalMesh/default.ht

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
# # #

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.mesh-lawyers.net/

Read the full story at http://www.prweb.com/releases/tranvaginal-mesh-lawsuit/vaginal-mesh-complication/prweb10578668.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Transvaginal Mesh Lawyer Applauds PBS Program Questioning FDA’s Approval of Pelvic Mesh Products
2. Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conferences in Federal Transvaginal Mesh Litigations
3. Vaginal Mesh Side Effect Sufferer Wins $3.35 Million Lawsuit; Transvaginal Mesh Attorney Jeff Nadrich Responds
4. US Drug Watchdog Now Urges Trial Law Firms To Join Them In A Effort To Help The Most Severely Injured Victims Of A Transvaginal Mesh Failure-With A Local Approach
5. US Drug Watchdog Now Urges Personal Injury Law Firms To Help Them Help Injured Individuals Of A Transvaginal Mesh Failure With A State Specific Approach-The Worst Victims
6. US Drug Watchdog Now Urges Top Personal Injury Trial Lawyers To Join Their State Specific Effort To Help Victims Of A Severe Transvaginal Mesh Failure To Get Compensation
7. US Drug Watchdog Now Invites Top Personal Injury Law Firms To Join Them In A State Specific Effort To Identify And Help Victims Of A Severe Transvaginal Mesh Failure
8. US Drug Watchdog Now Urges AV Rated Law Firms To Help Them Help More Victims Of A Severe Transvaginal Mesh Failure With A State Specific Approach
9. $3.35 Million Awarded in First Transvaginal Mesh Trial Verdict: Prompts McDonaldWorley.com Support Expansion
10. US Drug Watchdog Now Urges Trial Law Firms To Join Them In Their Effort To Help Severely Injured Victims Of A Transvaginal Mesh Failure-With A State Specific Approach
11. US Drug Watchdog Now Urges Victims Of A Transvaginal Mesh Failure To Call Them For The Names And Contacts Of Women Attorneys Who Also Have A Medical Background
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2017)... ... August 22, 2017 , ... Five Star Glass is new to the Texas market, but ... of auto glass for most makes and models, in Grand Prairie, TX, located in the ... They have been a family owned business for the past 40 years with 32 convenient ...
(Date:8/22/2017)... ... , ... “Wilderness Voices”: a collection of poetry inspired by life on a ... of published author, Martha McKown, an ordained United Methodist minister with graduate degrees in ... when her older sisters studied High School literature. She loved the early English ...
(Date:8/22/2017)... ... August 22, 2017 , ... “Covert Awakening”: ... creation of published author, Julianne Hale, a consultant for the Intelligence Community. ... expert focusing on the Near East region. Julianne has written hundreds of ...
(Date:8/22/2017)... Raleigh, North Carolina (PRWEB) , ... August 22, ... ... senior strategic advisor. Mr. Stewart is the Founder and Managing Member for t4 ... elements that have become critical to his definition of “success”: physician leadership development, ...
(Date:8/22/2017)... ... ... “Call Of Spiritual Duty”: a revelation in an era defined by intentional ... Growing up on the streets of North Visalia, California, Carlos Lizarde quickly became familiar ... keys to his life, he noticed immediately that opportunities and blessings began to shift ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017   Mostyn Law and Gulf ... Houston, Texas . The Mostyn Law family ... 2 years. That is why Mostyn Law is partnering ... to show its appreciation. Blood supplies are running ... 5% short of hospital needs in August. That is why the ...
(Date:8/14/2017)... Israel , Aug. 15, 2017 /PRNewswire/ ... of adult stem cell technologies for neurodegenerative diseases, announced ... 2017. "We are ... Phase 3 trial to investigate NurOwn ® in ... Executive Officer of BrainStorm. "We have agreements with Mass. ...
(Date:8/7/2017)... , Aug. 7, 2017 Insightin Health, ... acquisition, retention, and engagement, announced the selection of ... and Product Development, effective as of February 2017. In ... technology implementation strategy for our clients. Wood brings ... in consulting and business analytics within the healthcare ...
Breaking Medicine Technology: